Noxopharm Limited Is An Australian Biotech Company Listed On The Asx Under The Code Noxthe Company Specializes In The Discovery And Development Of Innovative Treatments For Cancer And Inflammationas Well As Enhancements To Mrna Vaccinesnoxopharm Is Led By Ceo Mrgraham Kelly And Non Executive Chair Mrfrederick Bart The Company Is Developing Several Key Productsincluding Veyondaidronoxil An Adjuvant Drug For Radiotherapy That Is Currently In Clinical Trialsnoxopharm Also Has Preclinical Technology Platformssofra And Chromawhich Focus On Improving Mrna Technologies And Oncologyrespectivelyadditionallynoxopharm Holds A Significant Stake In Nyrada Inca Us Biotech Company That Develops Drugs For Cardiovascular And Neurological Diseasesthe Company Collaborates With Pharmoragewhich Has Contributed Technology To Its Preclinical Pipeline
No conferences found for this company.
| Company Name | Noxopharm Ltd |
| Country |
Australia
|
| Address | Level 4 828 Pacific Highwaygordon 2072 Nsw Australiapo Box 824 Turramurra2074 Nsw Australia |
| Telephone | Login to View |
| Login to View |
